Our Mission

Human-like Tissues

Utilizing a passionate and talented team, VoxCell is providing an extraordinary line of human-like tissue solutions for the drug development industry and the field of Oncology research by creating 3D vascularized cancer tissue models. Our 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D bioprinted tissues. Combined with our proprietary software, we are able to print tissues with vasculature for more meaningful in vitro testing. This process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional extrusion based 3D bioprinters.

Our tissue models will increase confidence in new drug candidates, decrease the failure rate (currently more than 95% of drugs in the pipeline fail), and impact the speed for new therapies to get to market. The successful translation between pre-clinical trial data and clinical trial results is less than 8% and we are on a mission to change that.

 

Testing on human-like tissues will provide better data to identify and eliminate unsuccessful drug candidates sooner, increasing the throughput and reducing the volume and cost of animal and human testing, ultimately getting life saving therapies to market and in the hands of people who need them sooner.

Meet the team

Karol Small_edited.png
Untitled design (3)_edited.png

Karolina Valente, Ph.D.
CEO, CSO

tim_cropped (1)_edited_edited.png
Untitled design (3)_edited.png

Tim Cummings
Director of
Engineering

IMG_4758_edited_edited_edited.png
Untitled design (3)_edited.png

Kevin Vos, Ph.D.
Director of
Preclinical R&D

Copy of Charlotte QR_edited.png
Untitled design (3)_edited.png

Renato Maureira
Admin/Finance/HR Coordinator

Cameron Polglase_edited.png
Untitled design (3)_edited.png

Cameron Polglase
Lead Product Development
Engineer

Charlotte_edited_edited.png
Untitled design (3)_edited.png

Charlotte Ellis, Ph.D.
Lead Chemist

unnamed-2_edited_edited_edited_edited.png
Untitled design (3)_edited.png

Megan Chisling
Product Development Engineer

Ben2022_edited.png
Untitled design (3)_edited.png

Benjamin Rampado
Chemist

Ian DeJong.png
Untitled design (3)_edited.png

Ian DeJong
Software Engineer

CO-Op students

ESS interview_edited_edited.png
Untitled design (3)_edited.png

Sue Youn Kim
Tissue Engineering

Voxcell photo_edited.png
Untitled design (3)_edited.png

Jan McAslan
Engineering

advisors and partners

Brolo Small_edited.png
Untitled design (3)_edited.png

Alexandre Brolo, Ph.D.
Partner

unnamed-5_edited_edited.png
Untitled design (3)_edited.png

Nathan Lindquist, Ph.D.
Advisor
Optics

Dave Leitch.png
Untitled design (3)_edited.png

Dave Leitch, Ph.D.
Advisor
Pharma

Davy%2520headshot_edited_edited_edited.png
Untitled design (3)_edited.png

Emma Davy, Ph.D.
Advisor
Chemistry

AChubbs_edited.png
Untitled design (3)_edited.png

Alvin Chubbs
Advisor
Business & Finances

FB_IMG_1532370391877_edited.png
Untitled design (3)_edited.png

Curtis Evans
Advisor
Engineering

madhu_edited.png
Untitled design (3)_edited.png

Madhu SinghPh.D.
Advisor
Oncology

Georgina Rizik.png
Untitled design (3)_edited.png

Georgina Rizik, MBA.
Advisor
Strategy

jj-ying-7JX0-bfiuxQ-unsplash_edited.jpg

BOARD Members

Karol Small_edited.png
Untitled design (3)_edited.png

Karolina Valente, Ph.D.
CEO, Board

IMG_1086_edited.png
Untitled design (3)_edited.png

Nina Vellani, Ph.D.
Board

Levak_Rob_3322-M Photo 2020_edited_edited.png
Untitled design (3)_edited.png

Robert Levak
Board